Helping Premature Babies Breathe Without a Breathing Machine

What a 2026 study of babies born at 30–34 weeks (Ariyapadi and colleagues, Journal of Perinatology) means for families

A hospital in Dallas found that a simple, standardized way of supporting the breathing of babies born about six to ten weeks early cut the number who needed a mechanical breathing machine by roughly four-fold—from about 18 in 100 down to about 4 in 100—without any increase in complications. The key was giving lung medicine called surfactant through a thin, soft tube while the baby kept breathing on their own, instead of placing a breathing tube down the windpipe. This gives many families reassurance that a gentler approach can work well for moderately premature babies [1].

Why This Question Matters

When a baby is born early, one of the first worries is breathing. Premature lungs are often stiff and low on a natural soapy substance called surfactant, which keeps the tiny air sacs from collapsing. Without enough surfactant, those air sacs tend to close down after each breath, so the baby has to work harder and harder just to keep the lungs open, and often needs extra oxygen. This is why so much of newborn intensive care focuses on the lungs in the first hours and days of life. Babies born very early—before 30 weeks—have been studied intensively, and doctors have good, well-tested ways to help them. But babies born a little later, at 30 to 34 weeks, have received surprisingly little research attention, even though they make up the large majority of babies admitted to newborn intensive care units (NICUs) [2][3]. Most of these "moderate-to-late" premature babies do well, but a meaningful number still struggle to breathe and end up needing a ventilator, a machine that pushes air into the lungs through a tube placed in the windpipe [4].

Why does it matter whether a baby is on a ventilator or on gentler support? Ventilators are lifesaving, and sometimes they are absolutely necessary. But because they push air in under pressure through a tube in the windpipe, they can, over days, irritate and injure delicate newborn lungs, and the tube itself requires sedation and careful management. Keeping a baby breathing on their own whenever it is safe to do so is therefore a genuine goal of modern newborn care—not just a convenience, but a way to protect the lungs while they mature.

How Babies Used to Be Helped—and What Changed

For decades, the standard way to give surfactant was to place a breathing tube, deliver the medicine, and connect the baby to a ventilator. Ventilators save lives, but pushing air into fragile newborn lungs can also cause injury over time, so doctors have long looked for gentler options [5]. A major step forward came when studies showed that many premature babies could simply be supported with CPAP—continuous positive airway pressure, a steady cushion of air delivered through soft nasal prongs—rather than being put on a ventilator right away [6][7]. Then came an even gentler idea: instead of placing a breathing tube to give surfactant, doctors could slide a very thin, flexible catheter briefly into the windpipe, deliver the surfactant, remove the catheter, and let the baby keep breathing on CPAP the whole time. This technique, called "less invasive surfactant administration," or LISA, has been shown in careful studies to reduce the need for ventilators and improve outcomes in the smallest babies [8][9]. The open question was whether the same gentle approach would help the larger, slightly more mature 30–34 week babies. Until this study, that had never been directly examined [1].

It is worth pausing on what this uncertainty has meant for families over the years. Because the big research trials focused on the tiniest babies, care teams looking after a 30-to-34-week baby often had to rely on judgment and local habit rather than clear evidence. Two equally caring, experienced units might handle the same baby quite differently—one moving quickly to a breathing tube, another persevering with gentler support. For parents, that variation can be bewildering and, at times, a source of worry. A well-defined plan grounded in evidence does not remove every uncertainty, but it makes care more consistent and easier to explain, which is part of why studies like this one matter beyond the numbers.

What the Researchers Did

Doctors at Parkland Hospital in Dallas introduced a clear, step-by-step breathing-care plan in late 2018 and then compared how babies did before and after it began [1]. They looked at 325 babies born at 30–34 weeks in the period before the plan and 395 babies born after it. The plan itself was simple to follow: every baby with breathing difficulty was placed on CPAP; if the baby needed extra oxygen, the CPAP pressure was raised step by step; and if the baby still needed extra oxygen at the higher pressure, surfactant was given through the thin catheter. Only if a baby needed a great deal of oxygen or had frequent pauses in breathing would a full breathing tube be placed. The main thing the researchers measured was how many babies needed a mechanical ventilator in the first three days of life [1].

What They Found

The change was striking. Before the plan, about 18 of every 100 babies needed a ventilator in the first three days; after the plan, only about 4 of every 100 did—a roughly four-fold reduction [1]. The improvement showed up in both the younger (30–32 week) and older (33–34 week) babies. Interestingly, the plan did not mean giving surfactant to more babies overall; about the same fraction received it. What changed was the way it was given—through the thin catheter rather than through a breathing tube. Among the babies who did receive surfactant, the difference was dramatic: almost all of them had needed a ventilator under the old approach, compared with fewer than one in five under the new approach [1].

There was another encouraging detail. Among the babies who were still eventually placed on a ventilator despite the new plan, this tended to happen later—after about a day, rather than within the first few hours. In other words, the plan did not just postpone the inevitable; for many babies it turned what would have been a ventilator course into a stable stretch of breathing on their own. And the amount of extra oxygen a baby needed just before receiving surfactant was a little lower under the new plan, a sign that the team was stepping in a bit earlier rather than waiting for a baby to tire out [1].

Just as importantly, this gentler approach appeared to be safe. There was no increase in collapsed lungs, chronic lung disease, serious bleeding in the brain, a dangerous bowel condition, or death [1]. One honest limitation the researchers noted: the babies did not go home any sooner. How long a premature baby stays in the NICU depends mostly on feeding, growing, and outgrowing breathing pauses—things a breathing-care plan does not directly change [1]. So the promise of this approach is a gentler start and fewer babies on ventilators, rather than a shorter overall hospital stay.

What This Means for Families

If your baby is born at 30–34 weeks and needs help breathing, this study offers genuine reassurance that avoiding a ventilator is often possible, and that a brief bedside procedure to deliver surfactant through a thin tube—while your baby keeps breathing on their own—can be a safe and effective choice. It is worth knowing that this was a study at a single hospital comparing two time periods rather than a head-to-head experiment, so the exact size of the benefit may be smaller elsewhere, and results depend heavily on having a skilled, well-trained NICU team [1][10]. It is always reasonable to ask your baby's care team how they decide between CPAP, surfactant, and a ventilator, and whether the thin-catheter method is used in their unit.

What Researchers Are Working On Next

The most useful next step would be a larger study across many hospitals that randomly assigns babies to the new plan or to usual care, so the benefit can be measured more precisely [11]. Researchers are also studying whether giving the stimulant medicine caffeine at the same time as surfactant makes the gentle approach work even better [12], and whether combining better breathing care with better feeding and growth support could finally help these babies go home sooner. For now, the message is hopeful: for the large group of moderately premature babies, gentler breathing care that keeps many of them off the ventilator appears both achievable and safe.

If you are the parent of a baby born at this stage, it can help to remember that needing breathing support—whether CPAP, surfactant, or even a ventilator for a time—is common and expected, not a sign that something has gone wrong. Each of these tools has its place, and skilled teams choose among them based on how your baby is doing hour to hour. What studies like this one are steadily adding is a clearer, gentler roadmap for that decision, so that fewer babies than in the past will need the most invasive support to get the same good outcome.

References

  1. Ariyapadi S, Bautista L, David L, Mazioniene K, Chiu M, Harville S, Burchfield P, Brown LS, Weydig H, Kakkilaya V. Effects of a respiratory care protocol incorporating less invasive surfactant administration in infants born at 30–34 weeks' gestation. Journal of Perinatology. 2026. doi:10.1038/s41372-026-02682-1 ↩
  2. Escobar GJ, McCormick MC, Zupancic JA, et al. Unstudied infants: outcomes of moderately premature infants in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2006;91:F238–F244. doi:10.1136/adc.2005.087031 ↩
  3. Hatch LD, Clark RH, Carlo WA, et al. Changes in use of respiratory support for preterm infants in the US, 2008–2018. JAMA Pediatr. 2021;175:1017–1024. doi:10.1001/jamapediatrics.2021.1921 ↩
  4. Debillon T, Tourneux P, Guellec I, Jarreau PH, Flamant C. Respiratory distress management in moderate and late preterm infants: the NEOBS study. Arch Pediatr. 2021;28:392–397. doi:10.1016/j.arcped.2021.03.010 ↩
  5. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med. 1994;331:1051–1055. doi:10.1056/NEJM199410203311603 ↩
  6. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358:700–708. doi:10.1056/NEJMoa072788 ↩
  7. Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362:1970–1979. doi:10.1056/NEJMoa0911783 ↩
  8. Göpel W, Kribs A, Ziegler A, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–1634. doi:10.1016/S0140-6736(11)60986-060986-0) ↩
  9. Dargaville PA, Kamlin COF, Orsini F, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST-A randomized clinical trial. JAMA. 2021;326:2478–2487. doi:10.1001/jama.2021.21892 ↩
  10. Dargaville PA, Gerber A, Johansson S, et al. Incidence and outcome of CPAP failure in preterm infants. Pediatrics. 2016;138:e20153985. doi:10.1542/peds.2015-3985 ↩
  11. Schmölzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ. 2013;347:f5980. doi:10.1136/bmj.f5980 ↩
  12. Katheria A, Ines F, Banerji A, et al. Caffeine and less invasive surfactant administration for respiratory distress syndrome of the newborn. NEJM Evid. 2023;2:EVIDoa2300183. doi:10.1056/EVIDoa2300183 ↩